Psagot Value Holdings’s Zomedica Corp. ZOM Stock Holding History

Psagot Value Holdings’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,089	Closed	-$3K	–	656
2023 Q1	$3K	Buy	+12,089	New	+$2.96K	﹤0.01%	401

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Psagot Value Holdings's ZOM Position: Q2 2023 in Review

Psagot Value Holdings sold out of Zomedica Corp. (ZOM) in Q2 2023, closing a stake of 12,089 shares — an estimated $3K sold.

Psagot Value Holdings first reported a position in ZOM in Q1 2023 and held it in 1 quarter. The position peaked at $3K in Q1 2023. 92 funds tracked by Wall St. Rank hold ZOM as of Q2 2023.

Psagot Value Holdings reported no remaining Zomedica Corp. position as of Q2 2023 after selling out during the quarter.
Psagot Value Holdings sold 12,089 Zomedica Corp. shares in Q2 2023, an estimated $3K.
Psagot Value Holdings first reported a position in Zomedica Corp. in Q1 2023 and held it in 1 quarter.
Psagot Value Holdings's Zomedica Corp. position peaked at $3K in Q1 2023.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2023.

Based on Psagot Value Holdings's 13F filing for Q2 2023, filed 3 Aug 2023.